Stebėti
Andrzej Mackiewicz
Andrzej Mackiewicz
Professor of Medicine, Poznan Medical University
Patvirtintas el. paštas wco.pl
Pavadinimas
Cituota
Cituota
Metai
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
110302012
Comprehensive molecular characterization of gastric adenocarcinoma
Cancer Genome Atlas Research Network
Nature 513 (7517), 202, 2014
50902014
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Cancer Genome Atlas Network
Nature 517 (7536), 576, 2015
32092015
Improved overall survival in melanoma with combined dabrafenib and trametinib
C Robert, B Karaszewska, J Schachter, P Rutkowski, A Mackiewicz, ...
New England Journal of Medicine 372 (1), 30-39, 2015
28902015
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
26572015
Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma
C Robert, JJ Grob, D Stroyakovskiy, B Karaszewska, A Hauschild, ...
New England Journal of Medicine 381 (7), 626-636, 2019
11482019
The soluble interleukin‐6 receptor is generated by shedding
J Mülberg, H Schooltink, T Stoyan, M Günther, L Graeve, G Buse, ...
European journal of immunology 23 (2), 473-480, 1993
6601993
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
PA Ascierto, M Del Vecchio, C Robert, A Mackiewicz, V Chiarion-Sileni, ...
The Lancet Oncology 18 (5), 611-622, 2017
5002017
Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins.
A Mackiewicz, H Schooltink, PC Heinrich, S Rose-John
Journal of immunology (Baltimore, Md.: 1950) 149 (6), 2021-2027, 1992
4851992
Characterization of HPV and host genome interactions in primary head and neck cancers
M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ...
Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014
4152014
Interleukin‐6 serum levels in depressed patients before and after treatment with fluoxetine
A Służewska, JK Rybakowski, M Laciak, A Mackiewicz, M Sobieska, ...
Annals of the New York Academy of Sciences 762 (1), 474-476, 1995
3971995
Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines.
A Mackiewicz, T Speroff, MK Ganapathi, I Kushner
Journal of immunology (Baltimore, Md.: 1950) 146 (9), 3032-3037, 1991
3281991
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised …
AMM Eggermont, CU Blank, M Mandalà, GV Long, VG Atkinson, S Dalle, ...
The lancet oncology 22 (5), 643-654, 2021
2892021
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous …
JJ Grob, MM Amonkar, B Karaszewska, J Schachter, R Dummer, ...
The Lancet Oncology 16 (13), 1389-1398, 2015
2792015
A high proportion of founder BRCA1 mutations in Polish breast cancer families
B Górski, A Jakubowska, T Huzarski, T Byrski, J Gronwald, E Grzybowska, ...
International journal of cancer 110 (5), 683-686, 2004
2582004
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
M Maio, K Lewis, L Demidov, M Mandalà, I Bondarenko, PA Ascierto, ...
The Lancet Oncology 19 (4), 510-520, 2018
2262018
Aspects of the tumor microenvironment involved in immune resistance and drug resistance
K Khalaf, D Hana, JTT Chou, C Singh, A Mackiewicz, M Kaczmarek
Frontiers in immunology 12, 656364, 2021
2092021
Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis.
J Breborowicz, A Mackiewicz, D Breborowicz
Scandinavian Journal of Immunology 14 (1), 1981
2061981
Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials
D Schadendorf, GV Long, D Stroiakovski, B Karaszewska, A Hauschild, ...
European Journal of Cancer 82, 45-55, 2017
1942017
Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applications
S Hombach-Klonisch, S Panigrahi, I Rashedi, A Seifert, E Alberti, P Pocar, ...
Journal of Molecular Medicine 86, 1301-1314, 2008
1872008
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20